Portland-based Oregon Health & Science University reported an operating income of $135 million (2.2% margin) in fiscal year 2026, up from an operating loss of $118 million (-2.1% margin) in fiscal year 2025, according to the system’s Oct. 21 financial report.
Here are seven things to know:
1. OHSU’s net income was $512 million in fiscal year 2026, up from $74 million in fiscal year 2025.
2. The health system’s operating revenue was $6.3 billion, up from $5.5 billion the previous year. Operating expenses were $6.2 billion, up from $5.6 billion.
3. The health system’s net patient revenue rose 20.3% year over year. This was driven by 10.2% volume growth and 10.1% from acuity, collections and rates. Clinical revenue growth of 18.5% outpaced expense growth of 9.4%, cancer services increased 30% and case-mix index increased 3.5%. Supply chain and revenue cycle initiatives also contributed to the system’s improvement, and full-time equivalent growth was held to 2%.
4. Gains outside of operations added to the bottom line. OHSU saw $203 million in investment returns and $148 million in gains from its interest in the OHSU Foundation.
5. OHSU had 139 days cash on hand as of June 30, 2026, up from 133 a year earlier. Cash and investments also saw an increase of $140 million. The system’s long-term debt was relatively flat year over year at $1.3 billion.
6. OHSU also saw approximately $22 million in costs tied to ending its integrated health system affiliation with Roseville, Calif.-based Adventist Health. The two systems signed a termination agreement Nov. 7, 2025, and OHSU agreed to pay Adventist $23 million in two installments of $11.5 million due on June 30, 2026, and June 30, 2027.
7. The health system provided $15 million in operating support to Hillsboro (Ore.) Medical Center in fiscal year 2026 and recorded a full reserve against a $19.6 million capital loan to the hospital.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
